Tilmicosin phosphate
.png)
.png)
.png)
.png)
Tilmicosin phosphate
Tilmicosin bụ ọgwụ ọgwụ anụmanụ na-emepụta ọgwụ, a na-ejikarị ya maka mgbochi na ọgwụgwọ nke oyi baa na mastitis nke nje bacteria na-akpata, yana maka ọrịa mycoplasma na ezì na ọkụkọ.
Nkà mmụta ọgwụ
(1)Pharmacodynamics:Mmetụta nje na-egbu egbu yiri nke tylosin, ọkachasị megide nje bacteria gram-positive, ma dịkwa irè megide nje bacteria gram-adịghị mma na mycoplasma ole na ole.Ọrụ ya megide Actinobacillus pleuropneumoniae, Pasteurella na Mycoplasma nke anụ ụlọ na anụ ọkụkọ siri ike karịa tylosin.A kọwo na 95% nke ụdị Pasteurella hemolytica na-enwe mmetụta maka ngwaahịa a.
(2)Pharmacokinetics:Mgbe nchịkwa ọnụ ma ọ bụ ntụtụ subcutaneous, ngwaahịa a nwere nnabata ngwa ngwa, ntinye anụ ahụ siri ike yana oke nkesa.
Mkpachapụ anya
(1) Amachibidoro ogwu ogwu n'ime ala nke ngwaahịa a.Otu ogwu ogbugba nke 5 mg/kg na-egbu ehi, ọ dịkwa ize ndụ maka ezì, primates na ịnyịnya.
(2) Mmeghachi omume mpaghara (edema, wdg) nwere ike ime na intramuscular na subcutaneous injections, na ha enweghị ike ime ka ha na anya.Ekwesịrị ịhọpụta ebe ịgba ntụtụ nke subcutaneous na mpaghara dị n'azụ ubu ehi n'ọgịrịga ahụ.
(3) Akụkụ ebumnuche nke mmetụta nsị nke ọgwụ a bụ obi, nke nwere ike ibute tachycardia na mbelata nkwekọrịta.(4) Ekwesịrị ileba anya nke ọma ọnọdụ obi mgbe ị na-eji ngwaahịa a.
(5) Ekwesịrị iji ọgwụ ogbugba nke ngwaahịa a na-akpachapụ anya na anụmanụ ndị ọzọ karịa ehi.
(6) N'ime oge nkwụsịtụ, a na-eme injection subcutaneous maka ụbọchị 28, a na-ejikwa ọnụ ezì maka ụbọchị 14.A machibidoro ehi mmiri ara ehi na nwa ehi n'oge mmiri ara ehi.
Ọdịnaya
≥ 98%
Nkọwapụta
USP/CVP
Nkwakọ ngwaahịa
25kg / kaadiboodu drum
Nkwadebe
10%, 20%, 37.5% Tilmicosin phosphate soluble ntụ ntụ;
10%, 20%tilmicosin phosphate onu ngwọta
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.
